Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2006
04/05/2006CN1249049C Cyclic disulfide, producing process thereof and optical products containing the same
04/05/2006CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
04/05/2006CN1249036C Iron chelators and use thereof
04/04/2006US7022736 Enzyme inhibitors
04/04/2006US7022731 Cardiovascular disorders; thrombosis; anticoagulants
04/04/2006US7022718 Pyridine and pyrimidine derivatives
04/04/2006US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/04/2006US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
04/04/2006US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes
04/04/2006US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
04/04/2006US7022650 Herbicides for broadleaf/gramineous weeds among crop plants
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
04/04/2006CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
04/04/2006CA2198266C Novel benzimidazole derivatives
04/04/2006CA2193039C Indol-2-one derivatives
04/04/2006CA2132134C Benzofuran-2-ones as stabilisers
04/04/2006CA2043976C Substituted phthalides and heterocyclic phthalides
03/2006
03/30/2006WO2006034480A2 Sulfonamide bicyclic compounds
03/30/2006WO2006034111A1 (arylamidoaryl)squaramide compounds
03/30/2006WO2006034016A1 (arylamidoanilino) nitroethylene compounds
03/30/2006WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors
03/30/2006WO2006033796A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME
03/30/2006WO2006033406A1 Method for producing cyclic sulfide compound and intermediate thereof
03/30/2006WO2006033405A1 Cyclic sulfide compound and optical article using same
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006WO2006032869A1 Dna-pk inhibitors
03/30/2006WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006WO2006010544A3 1, 1a, 5, 5a-tetrahydro-3-thia-cyclopropa’a! pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists
03/30/2006WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
03/30/2006WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
03/30/2006US20060069147 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease
03/30/2006US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
03/30/2006US20060069121 N-(3-{[1-(dimethylamino)-2-nitrovinyl]amino}phenyl)-3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide; neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma
03/30/2006US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/30/2006US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide
03/30/2006US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/30/2006US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood
03/30/2006US20060069090 Triazine compounds
03/30/2006US20060069084 Methods of inhibiting kinases
03/30/2006US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
03/30/2006US20060069034 Antipathogenic benzamide compounds
03/30/2006DE102005043371A1 Thiophenderivat und organisches elektrolumineszierendes Element Thiophene derivative and organic electro-luminescent element
03/30/2006CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors
03/30/2006CA2580229A1 Dna-pk inhibitors
03/29/2006EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
03/29/2006EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels
03/29/2006EP1638944A1 Tachykinin receptor antagonists
03/29/2006EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
03/29/2006EP1638942A1 Cis-2,4,5-triaryl-imidazolines
03/29/2006EP1638940A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
03/29/2006EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/29/2006EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake
03/29/2006EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/29/2006CN1753889A Quinazoline compounds
03/29/2006CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
03/29/2006CN1753876A New pyridazin-3(2h)-one derivatives
03/29/2006CN1753872A Process for the production of substituted nicotinic acid esters
03/29/2006CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors
03/29/2006CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor
03/29/2006CN1752084A Heterocycle containing fluorene kind derivative and its preparation method
03/29/2006CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
03/29/2006CN1247541C Cyclic imines as pesticides
03/29/2006CN1247529C Process for preparing N-aroyl-L-glutaminic acid
03/28/2006US7019453 For use as optical modulators, optical switches, and optical directional couplers
03/28/2006US7019030 Immunotherapeutic agents
03/28/2006US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases)
03/28/2006US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress
03/28/2006US7019008 Pyrrolidine sulfonamides
03/28/2006US7019006 Compounds useful as anti-inflammatory agents
03/28/2006US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor
03/28/2006US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
03/28/2006US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors
03/28/2006CA2263417C Arylalkanoylpyridazines
03/28/2006CA2244862C Substituted amide derivatives
03/28/2006CA2153805C C10 taxane derivatives and pharmaceutical compositions
03/23/2006WO2006030984A1 Piperidine compound and process for preparing the same
03/23/2006WO2006030975A1 Piperidine derivatives and use thereof
03/23/2006WO2006030931A1 N-substituted n-(4-piperidinyl)amide derivative
03/23/2006WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
03/23/2006WO2006030805A1 Triazole derivative or salt thereof
03/23/2006WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006WO2006029912A1 Indole derivatives as antiviral agents
03/23/2006WO2006029867A1 5-heterocyclyl pyrimidines
03/23/2006WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides
03/23/2006WO2006029811A1 Method for manufacturing enantiomeric imidazole compounds
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006WO2005108355A3 Dihydrobenzothiophenes
03/23/2006US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
03/23/2006US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/23/2006US20060063799 Sulfonamide bicyclic compounds
03/23/2006US20060063796 Pyrazoles as inhibitors of tumor necrosis factor
03/23/2006US20060063791 (Spirocyclylamido)aminothiophene compounds
03/23/2006US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
03/23/2006US20060063781 Pharmaceutical composition for regeneration of cirrhotic liver
03/23/2006US20060063773 (Hydrazido)(amino)thiophene compounds